Throughout the course of routine clinical practice, real-world data are obtained from various
sources, including medical claims, product and disease registries, electronic health records …

(RWE) in scientific papers and the lay media. Although some researchers and journalists
tout its value, opponents are vocal in challenging its validity, pointing out shortcomings and …

One substantial limitation of randomized clinical trials (RCTs) relates to the stringent
eligibility criteria that are typically used. As a result, only a small percentage of patients who …

One of the most significant challenges in medicine is striking a balance between what is best
for the patient's well-being and what is most cost effective. The bottom line remains that …

A primary finding of the NAS study is confirmation of the vital role of nuclear medicine in
delivering on the promise of personalized medicine, which is contingent on medicine's …

Information to guide the delivery of optimal cancer care has traditionally been developed
through the conduct of prospective clinical trials sponsored by the National Cancer Institute …

Recent advances in technology and discovery have led to a key role for nuclear medicine in
precision health and individualized patient care. As we enter this era of promise and growth …

Background The development of radiopharmaceuticals requires extensive evaluation before
they can be applied in a diagnostic or therapeutic setting in Nuclear Medicine. Chemical …

(NBDA), created to engage leaders in industry, academia, patient groups, and government
from across the country, was announced on January 13 at the National Press Club …

The problem: The Nuclear Regulatory Commission (NRC) is the federal agency tasked with
protecting public health and safety related to radiopharmaceuticals used in nuclear …